Abstract
Justicidin B (JB) is a biologically active arylnaphthalene lignan with significant therapeutic potential. However, its clinical application is limited by poor solubility and stability. In this study, cinnamyl-functionalized polyglycidol–poly(ε-caprolactone) (PG–PCL) polymeric micelles are developed and evaluated as nanocarriers for JB delivery. Both modified and non-modified micelles formed stable nanosystems (In vitro cytotoxicity assays showed significantly improved antiproliferative activity against HL-60 leukemia cells (IC 50 = 3.65 μg/mL) compared to free JB (IC 50 = 6.65 μg/mL) and non-modified micelles (IC 50 = 9.14 μg/mL), while maintaining low toxicity toward normal cells. These findings highlight cinnamyl-functionalized micelles as a promising platform for enhancing the therapeutic performance of hydrophobic anticancer agents.

This publication has 21 references indexed in Scilit: